All Roll Calls
Yes: 261 • No: 0
NebraskaLB195109th Legislature 1st and 2nd SessionslegislatureWALLET
Provide immunity for administration of naloxone, nalmefene, or other federally approved opioid overdose reversal medications
Sponsored By: Glen Meyer
Signed by Governor
Judiciary Committee
Your PRIA Score
Score Hidden
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Covers all FDA-approved overdose antidotes
The law defines opioid overdose reversal medication to include any FDA‑approved drug, such as naloxone and nalmefene. It applies whether the drug is prescribed, given by a health professional, or bought over the counter. It also defines who counts as health professionals, emergency responders, peace officers, and law‑enforcement employees for these protections.
Protections for EMTs and police
The law shields EMTs, paramedics, and other emergency responders who, in good faith, use overdose‑reversal drugs supplied by their EMS employer. They are not subject to job discipline or criminal charges and are not personally liable for damages unless their actions are willful, wanton, or grossly negligent. Peace officers and law‑enforcement employees get the same protections when using drugs supplied by their agency. The employer or agency’s own liability is not changed.
Protections for prescribers and bystanders
The law protects licensed doctors, physician assistants, nurse practitioners, and pharmacists who act with reasonable care when they prescribe, give, or dispense opioid overdose drugs. It also protects family, friends, school staff, and other laypeople who act in good faith to get the drug by prescription or over the counter and give it during an overdose. These people face no criminal charges or professional discipline for doing so. Covered drugs include FDA‑approved overdose antidotes like naloxone and nalmefene.
Sponsors & Cosponsors
Sponsor
Glen Meyer
legislature
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
legislature vote • 4/24/2026
Vote
Yes: 43 • No: 0 • Other: 6
legislature vote • 4/24/2026
Vote
Yes: 42 • No: 0 • Other: 7
legislature vote • 4/3/2025
Final Reading
Yes: 47 • No: 0 • Other: 2
legislature vote • 2/26/2025
Vote
Yes: 44 • No: 0 • Other: 5
legislature vote • 2/26/2025
Vote
Yes: 43 • No: 0 • Other: 6
legislature vote • 2/26/2025
Vote
Yes: 42 • No: 0 • Other: 7
Actions Timeline
Approved by Governor on April 7, 2025
4/8/2025legislaturePassed on Final Reading 47-0-2
4/3/2025legislaturePresident/Speaker signed
4/3/2025legislaturePresented to Governor on April 3, 2025
4/3/2025legislaturePlaced on Final Reading
3/19/2025legislatureAdvanced to Enrollment and Review for Engrossment
3/11/2025legislaturePlaced on Select File
3/4/2025legislatureBosn AM240 adopted
2/26/2025legislatureJudiciary AM135 adopted
2/26/2025legislatureAdvanced to Enrollment and Review Initial
2/26/2025legislatureBosn AM240 to AM135 filed
2/21/2025legislatureHallstrom name added
2/11/2025legislaturePlaced on General File with AM135
2/10/2025legislatureJudiciary AM135 filed
2/10/2025legislatureReferred to Judiciary Committee
1/16/2025legislatureNotice of hearing for January 23, 2025
1/16/2025legislatureDate of introduction
1/14/2025legislature
Bill Text
Introduced
4/8/2025
Enrolled / Slip Law
Final / Enacted